Considered as a thyroid oncogenic pathway, AKT/mTOR pathway is mostly hyperactivated in PTC, particularly in poorly differentiated thyroid cancer 31. The gene discussed is MTOR; the disease is poorly differentiated thyroid gland carcinoma.